Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 482 entries
Sorted by: Best Match Show Resources per page
Investigation on sensitized chemiluminescence systems and their mechanism for five fluoroquinolones.

Analytica chimica acta

Sun H, Li L, Chen X.
PMID: 17723632
Anal Chim Acta. 2006 Aug 25;576(2):192-9. doi: 10.1016/j.aca.2006.06.013. Epub 2006 Jun 16.

The novel chemiluminescence (CL) reaction systems were established for lomefloxacin (LMFX), ofloxacin(OFLX), norfloxacin (NFLX), gatifloxacin (GAFX) and enoxacin (ENX). The sensitized CL emission mechanism was investigated for the five systems by comparing the fluorescence emission with CL spectra. For...

Cite
Sun H, Li L, Chen X. Investigation on sensitized chemiluminescence systems and their mechanism for five fluoroquinolones. Anal Chim Acta. 2006;576(2):192-9doi: 10.1016/j.aca.2006.06.013.
Sun, H., Li, L., & Chen, X. (2006). Investigation on sensitized chemiluminescence systems and their mechanism for five fluoroquinolones. Analytica chimica acta, 576(2), 192-9. https://doi.org/10.1016/j.aca.2006.06.013
Sun, Hanwen, et al. "Investigation on sensitized chemiluminescence systems and their mechanism for five fluoroquinolones." Analytica chimica acta vol. 576,2 (2006): 192-9. doi: https://doi.org/10.1016/j.aca.2006.06.013
Sun H, Li L, Chen X. Investigation on sensitized chemiluminescence systems and their mechanism for five fluoroquinolones. Anal Chim Acta. 2006 Aug 25;576(2):192-9. doi: 10.1016/j.aca.2006.06.013. Epub 2006 Jun 16. PMID: 17723632.
Copy Download .nbib Format: NLM
Quinolone pharmacokinetics.

International journal of antimicrobial agents

Robson RA.
PMID: 18611512
Int J Antimicrob Agents. 1992 Dec;2(1):3-10. doi: 10.1016/0924-8579(92)90020-r.

Fluoroquinolones have broad antibacterial spectra and are active against most Gram-negative and many Gram-positive species. They exhibit excellent oral bioavailability, extensive tissue penetration, low protein binding, and a long elimination half-life. This review compares and contrasts the pharmakonetics of...

Cite
Robson RA. Quinolone pharmacokinetics. Int J Antimicrob Agents. 1992;2(1):3-10doi: 10.1016/0924-8579(92)90020-r.
Robson, R. A. (1992). Quinolone pharmacokinetics. International journal of antimicrobial agents, 2(1), 3-10. https://doi.org/10.1016/0924-8579(92)90020-r
Robson, R A. "Quinolone pharmacokinetics." International journal of antimicrobial agents vol. 2,1 (1992): 3-10. doi: https://doi.org/10.1016/0924-8579(92)90020-r
Robson RA. Quinolone pharmacokinetics. Int J Antimicrob Agents. 1992 Dec;2(1):3-10. doi: 10.1016/0924-8579(92)90020-r. PMID: 18611512.
Copy Download .nbib Format: NLM
Ofloxacin induced leucopenia in complicated falciparum malaria: a case report.

Cases journal

Tripathy S, Adhya A.
PMID: 19829908
Cases J. 2009 Jun 09;2:7097. doi: 10.4076/1757-1626-2-7097.

INTRODUCTION: To report a case of ofloxacin-associated leucopoenia, which occurred in a patient of falciparum malaria shortly after administration and resolved following discontinuation of the drug.CASE PRESENTATION: A 44 year old female was admitted in circulatory shock with a...

Cite
Tripathy S, Adhya A. Ofloxacin induced leucopenia in complicated falciparum malaria: a case report. Cases J. 2009;2:7097doi: 10.4076/1757-1626-2-7097.
Tripathy, S., & Adhya, A. (2009). Ofloxacin induced leucopenia in complicated falciparum malaria: a case report. Cases journal, 27097. https://doi.org/10.4076/1757-1626-2-7097
Tripathy, Swagata, and Adhya, Amit. "Ofloxacin induced leucopenia in complicated falciparum malaria: a case report." Cases journal vol. 2 (2009): 7097. doi: https://doi.org/10.4076/1757-1626-2-7097
Tripathy S, Adhya A. Ofloxacin induced leucopenia in complicated falciparum malaria: a case report. Cases J. 2009 Jun 09;2:7097. doi: 10.4076/1757-1626-2-7097. PMID: 19829908; PMCID: PMC2740107.
Copy Download .nbib Format: NLM
Targeting Multidrug Resistant Mycobacterium tuberculosis HtrA2 with Identical Chemical Entities of Fluoroquinolones.

Indian journal of pharmaceutical sciences

Daisy P, Vijayalakshmi P, Selvaraj C, Singh SK, Saipriya K.
PMID: 23440996
Indian J Pharm Sci. 2012 May;74(3):217-22. doi: 10.4103/0250-474X.106063.

Tuberculosis is a highly communicable and chronic respiratory disease caused by pathogenic bacterium Mycobacterium tuberculosis. The drug - resistant species of Mycobacterium tuberculosis are tough to cure due to its resistant activity toward potential drugs. Available inhibitors of tuberculosis...

Cite
Daisy P, Vijayalakshmi P, Selvaraj C, et al. Targeting Multidrug Resistant Mycobacterium tuberculosis HtrA2 with Identical Chemical Entities of Fluoroquinolones. Indian J Pharm Sci. 2012;74(3):217-22doi: 10.4103/0250-474X.106063.
Daisy, P., Vijayalakshmi, P., Selvaraj, C., Singh, S. K., & Saipriya, K. (2012). Targeting Multidrug Resistant Mycobacterium tuberculosis HtrA2 with Identical Chemical Entities of Fluoroquinolones. Indian journal of pharmaceutical sciences, 74(3), 217-22. https://doi.org/10.4103/0250-474X.106063
Daisy, P, et al. "Targeting Multidrug Resistant Mycobacterium tuberculosis HtrA2 with Identical Chemical Entities of Fluoroquinolones." Indian journal of pharmaceutical sciences vol. 74,3 (2012): 217-22. doi: https://doi.org/10.4103/0250-474X.106063
Daisy P, Vijayalakshmi P, Selvaraj C, Singh SK, Saipriya K. Targeting Multidrug Resistant Mycobacterium tuberculosis HtrA2 with Identical Chemical Entities of Fluoroquinolones. Indian J Pharm Sci. 2012 May;74(3):217-22. doi: 10.4103/0250-474X.106063. PMID: 23440996; PMCID: PMC3574531.
Copy Download .nbib Format: NLM
In vitro evaluation of microbiological flora of orofacial infections.

Journal of maxillofacial and oral surgery

Kohli M, Mathur A, Kohli M, Siddiqui SR.
PMID: 23139538
J Maxillofac Oral Surg. 2009 Dec;8(4):329-33. doi: 10.1007/s12663-009-0080-1. Epub 2010 Apr 24.

OBJECTIVE: To assess the most common micro-organisms causing odontogenic infections and their antimicrobial susceptibility.METHODS: The study was conducted in 80 patients with orofacial infection. The pus sample was collected, cultured (aerobically and anaerobically) and stained for morphological study of...

Cite
Kohli M, Mathur A, Kohli M, et al. In vitro evaluation of microbiological flora of orofacial infections. J Maxillofac Oral Surg. 2010;8(4):329-33doi: 10.1007/s12663-009-0080-1.
Kohli, M., Mathur, A., Kohli, M., & Siddiqui, S. R. (2009). In vitro evaluation of microbiological flora of orofacial infections. Journal of maxillofacial and oral surgery, 8(4), 329-33. https://doi.org/10.1007/s12663-009-0080-1
Kohli, Munish, et al. "In vitro evaluation of microbiological flora of orofacial infections." Journal of maxillofacial and oral surgery vol. 8,4 (2009): 329-33. doi: https://doi.org/10.1007/s12663-009-0080-1
Kohli M, Mathur A, Kohli M, Siddiqui SR. In vitro evaluation of microbiological flora of orofacial infections. J Maxillofac Oral Surg. 2009 Dec;8(4):329-33. doi: 10.1007/s12663-009-0080-1. Epub 2010 Apr 24. PMID: 23139538; PMCID: PMC3454097.
Copy Download .nbib Format: NLM
Patterns of antimicrobial resistance in the causative organisms of spontaneous bacterial peritonitis: a single centre, six-year experience of 1981 samples.

International journal of hepatology

Sheikhbahaei S, Abdollahi A, Hafezi-Nejad N, Zare E.
PMID: 24778884
Int J Hepatol. 2014;2014:917856. doi: 10.1155/2014/917856. Epub 2014 Mar 20.

Background/Aims. Spontaneous bacterial peritonitis (SBP) is one of the leading causes of morbidity and mortality in patients with cirrhosis. This study aims to determine the microbial agents of SBP and the pattern of antibiotic resistance, in a large number...

Cite
Sheikhbahaei S, Abdollahi A, Hafezi-Nejad N, et al. Patterns of antimicrobial resistance in the causative organisms of spontaneous bacterial peritonitis: a single centre, six-year experience of 1981 samples. Int J Hepatol. 2014;2014:917856doi: 10.1155/2014/917856.
Sheikhbahaei, S., Abdollahi, A., Hafezi-Nejad, N., & Zare, E. (2014). Patterns of antimicrobial resistance in the causative organisms of spontaneous bacterial peritonitis: a single centre, six-year experience of 1981 samples. International journal of hepatology, 2014917856. https://doi.org/10.1155/2014/917856
Sheikhbahaei, Sara, et al. "Patterns of antimicrobial resistance in the causative organisms of spontaneous bacterial peritonitis: a single centre, six-year experience of 1981 samples." International journal of hepatology vol. 2014 (2014): 917856. doi: https://doi.org/10.1155/2014/917856
Sheikhbahaei S, Abdollahi A, Hafezi-Nejad N, Zare E. Patterns of antimicrobial resistance in the causative organisms of spontaneous bacterial peritonitis: a single centre, six-year experience of 1981 samples. Int J Hepatol. 2014;2014:917856. doi: 10.1155/2014/917856. Epub 2014 Mar 20. PMID: 24778884; PMCID: PMC3980918.
Copy Download .nbib Format: NLM
Design and development of novel dual-compartment capsule for improved gastroretention.

ISRN pharmaceutics

Patil GB, Singh SS, Ramani KP, Chatap VK, Deshmukh PK.
PMID: 23431476
ISRN Pharm. 2013;2013:752471. doi: 10.1155/2013/752471. Epub 2013 Jan 27.

The aim of the proposed research work was to develop a novel dual-compartment capsule (NDCC) with polymeric disc for gastroretentive dosage form, which will ultimately result in better solubility and bioavailability of Ofloxacin. Floating ring caps were formulated by...

Cite
Patil GB, Singh SS, Ramani KP, et al. Design and development of novel dual-compartment capsule for improved gastroretention. ISRN Pharm. 2013;2013:752471doi: 10.1155/2013/752471.
Patil, G. B., Singh, S. S., Ramani, K. P., Chatap, V. K., & Deshmukh, P. K. (2013). Design and development of novel dual-compartment capsule for improved gastroretention. ISRN pharmaceutics, 2013752471. https://doi.org/10.1155/2013/752471
Patil, Ganesh B, et al. "Design and development of novel dual-compartment capsule for improved gastroretention." ISRN pharmaceutics vol. 2013 (2013): 752471. doi: https://doi.org/10.1155/2013/752471
Patil GB, Singh SS, Ramani KP, Chatap VK, Deshmukh PK. Design and development of novel dual-compartment capsule for improved gastroretention. ISRN Pharm. 2013;2013:752471. doi: 10.1155/2013/752471. Epub 2013 Jan 27. PMID: 23431476; PMCID: PMC3568882.
Copy Download .nbib Format: NLM
Rapid diagnosis of acanthamoeba keratitis using non-nutrient agar with a lawn of E. coli.

Journal of ophthalmic inflammation and infection

Borin S, Feldman I, Ken-Dror S, Briscoe D.
PMID: 23514313
J Ophthalmic Inflamm Infect. 2013 Feb 27;3(1):40. doi: 10.1186/1869-5760-3-40.

BACKGROUND: A patient presented with a corneal foreign body in his only eye. He was treated with prophylactic antibiotics and sent home, but deteriorated.FINDINGS: He returned to the hospital 5 days later, and on slit-lamp examination, there was ciliary...

Cite
Borin S, Feldman I, Ken-Dror S, et al. Rapid diagnosis of acanthamoeba keratitis using non-nutrient agar with a lawn of E. coli. J Ophthalmic Inflamm Infect. 2013;3(1):40doi: 10.1186/1869-5760-3-40.
Borin, S., Feldman, I., Ken-Dror, S., & Briscoe, D. (2013). Rapid diagnosis of acanthamoeba keratitis using non-nutrient agar with a lawn of E. coli. Journal of ophthalmic inflammation and infection, 3(1), 40. https://doi.org/10.1186/1869-5760-3-40
Borin, Samuel, et al. "Rapid diagnosis of acanthamoeba keratitis using non-nutrient agar with a lawn of E. coli." Journal of ophthalmic inflammation and infection vol. 3,1 (2013): 40. doi: https://doi.org/10.1186/1869-5760-3-40
Borin S, Feldman I, Ken-Dror S, Briscoe D. Rapid diagnosis of acanthamoeba keratitis using non-nutrient agar with a lawn of E. coli. J Ophthalmic Inflamm Infect. 2013 Feb 27;3(1):40. doi: 10.1186/1869-5760-3-40. PMID: 23514313; PMCID: PMC3605080.
Copy Download .nbib Format: NLM
Ofloxacin-induced toxic epidermal necrolysis.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

Gupta G.
PMID: 25136199
Indian J Crit Care Med. 2014 Aug;18(8):545-6. doi: 10.4103/0972-5229.138166.

No abstract available.

Cite
Gupta G. Ofloxacin-induced toxic epidermal necrolysis. Indian J Crit Care Med. 2014;18(8):545-6doi: 10.4103/0972-5229.138166.
Gupta, G. (2014). Ofloxacin-induced toxic epidermal necrolysis. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 18(8), 545-6. https://doi.org/10.4103/0972-5229.138166
Gupta, Gaurang. "Ofloxacin-induced toxic epidermal necrolysis." Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine vol. 18,8 (2014): 545-6. doi: https://doi.org/10.4103/0972-5229.138166
Gupta G. Ofloxacin-induced toxic epidermal necrolysis. Indian J Crit Care Med. 2014 Aug;18(8):545-6. doi: 10.4103/0972-5229.138166. PMID: 25136199; PMCID: PMC4134634.
Copy Download .nbib Format: NLM
Pyrazinamide-induced exfoliative dermatitis in a patient on hemodialysis: a rare complication.

Case reports in nephrology

Jaisuresh K.
PMID: 24527247
Case Rep Nephrol. 2013;2013:387293. doi: 10.1155/2013/387293. Epub 2013 Sep 18.

A 60-year-old male patient on maintenance hemodialysis was started on antituberculosis therapy with isoniazid, rifampin, ethambutol, and pyrazinamide for pulmonary tuberculosis. After 4 weeks of therapy, he developed pruritic lesions in the extremities followed by exfoliation. The lesions progressively...

Cite
Jaisuresh K. Pyrazinamide-induced exfoliative dermatitis in a patient on hemodialysis: a rare complication. Case Rep Nephrol. 2013;2013:387293doi: 10.1155/2013/387293.
Jaisuresh, K. (2013). Pyrazinamide-induced exfoliative dermatitis in a patient on hemodialysis: a rare complication. Case reports in nephrology, 2013387293. https://doi.org/10.1155/2013/387293
Jaisuresh, Krishnaswamy. "Pyrazinamide-induced exfoliative dermatitis in a patient on hemodialysis: a rare complication." Case reports in nephrology vol. 2013 (2013): 387293. doi: https://doi.org/10.1155/2013/387293
Jaisuresh K. Pyrazinamide-induced exfoliative dermatitis in a patient on hemodialysis: a rare complication. Case Rep Nephrol. 2013;2013:387293. doi: 10.1155/2013/387293. Epub 2013 Sep 18. PMID: 24527247; PMCID: PMC3914237.
Copy Download .nbib Format: NLM
Unusual presentation of phacolytic glaucoma: simulating microbial keratitis.

Case reports in ophthalmological medicine

Sahu SK, Keswarwani S, Mittal R.
PMID: 22606478
Case Rep Ophthalmol Med. 2011;2011:850919. doi: 10.1155/2011/850919. Epub 2011 Dec 20.

The differential diagnoses for phacolytic glaucoma are acute angle closure glaucoma, open angle glaucoma with uveitis, neovascular glaucoma, and glaucoma secondary to trauma. We report an unusual case where the dislocated cataractous lens firmly adherent to the corneal endothelium...

Cite
Sahu SK, Keswarwani S, Mittal R. Unusual presentation of phacolytic glaucoma: simulating microbial keratitis. Case Rep Ophthalmol Med. 2011;2011:850919doi: 10.1155/2011/850919.
Sahu, S. K., Keswarwani, S., & Mittal, R. (2011). Unusual presentation of phacolytic glaucoma: simulating microbial keratitis. Case reports in ophthalmological medicine, 2011850919. https://doi.org/10.1155/2011/850919
Sahu, Srikant Kumar, et al. "Unusual presentation of phacolytic glaucoma: simulating microbial keratitis." Case reports in ophthalmological medicine vol. 2011 (2011): 850919. doi: https://doi.org/10.1155/2011/850919
Sahu SK, Keswarwani S, Mittal R. Unusual presentation of phacolytic glaucoma: simulating microbial keratitis. Case Rep Ophthalmol Med. 2011;2011:850919. doi: 10.1155/2011/850919. Epub 2011 Dec 20. PMID: 22606478; PMCID: PMC3350162.
Copy Download .nbib Format: NLM
Chapter 6 ofloxacin.

Profiles of drug substances, excipients, and related methodology

Al-Omar MA.
PMID: 22469176
Profiles Drug Subst Excip Relat Methodol. 2009;34:265-98. doi: 10.1016/S1871-5125(09)34006-6. Epub 2010 Mar 16.

No abstract available.

Cite
Al-Omar MA. Chapter 6 ofloxacin. Profiles Drug Subst Excip Relat Methodol. 2010;34:265-98doi: 10.1016/S1871-5125(09)34006-6.
Al-Omar, M. A. (2009). Chapter 6 ofloxacin. Profiles of drug substances, excipients, and related methodology, 34265-98. https://doi.org/10.1016/S1871-5125(09)34006-6
Al-Omar, Mohammed A. "Chapter 6 ofloxacin." Profiles of drug substances, excipients, and related methodology vol. 34 (2009): 265-98. doi: https://doi.org/10.1016/S1871-5125(09)34006-6
Al-Omar MA. Chapter 6 ofloxacin. Profiles Drug Subst Excip Relat Methodol. 2009;34:265-98. doi: 10.1016/S1871-5125(09)34006-6. Epub 2010 Mar 16. PMID: 22469176.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 482 entries